Hormone receptor-positive breast cancer
Therapeutic area
Oncology
Rare disease
No
- Definition
- A breast carcinoma which is positive for expression of estrogen receptor (ER), progesterone receptor (PR), and is negative for expression of human epidermal growth factor receptor 2 (HER2).
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Hormone receptor-positive breast cancer
- Therapeutic area
- Oncology
- hormone receptor-positive breast cancer
- HR-positive HER2-negative breast cancer
- hormone receptor positive breast cancer
- All therapeutic areas
- Oncology
- Severity
- Severe
- MONDO ID
- MONDO:0700079
- Parent condition
- MONDO:0000615
Related records
Broader conditions (20)
- Breast cancer
- Breast carcinoma
- Breast carcinoma by gene expression profile
- Breast disorder
- Breast neoplasm
- Cancer
- Cancer or benign tumor
- Carcinoma
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Epithelial neoplasm
- Estrogen-receptor positive breast cancer
- Her2-receptor negative breast cancer
- Human disease
- Neoplasm
- Neoplasm of thorax
- Neoplastic disease or syndrome
- Progesterone-receptor positive breast cancer
- Thoracic cancer
Trials (89)
- A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
- A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer
- A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer
- A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer
- A Randomized Study Comparing the Immune Modulation Effect of Ribociclib, Palbociclib, and Abemaciclib in ER+/HER2- EBC
- A Safety Study of SGN-LIV1A in Breast Cancer Patients
- A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
- A Study in Patients With Advanced Breast Cancer
- A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
- A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
- A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
- A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors
- A Study of Fluvestrant Combined With Oral Vinorelbine in Hormone Receptor-positive Advanced Breast Cancer
- A Study of Revaree Plus in People With Breast Cancer
- A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
- A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer
- A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer
- A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
- Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
- ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer